The cardiovascular effects of glp-1 receptor agonists
Cardiovascular Therapeutics, 04/25/2012Okerson T et al.
Ongoing studies are examining the effects of administering GLP–1R agonists to patients at risk of CVD, postangioplasty patients, post–CABG patients, and patients with heart failure. Additional studies should provide meaningful data to determine whether GLP–1R agonists provide unique treatment benefits to patients at risk for or with established CVD.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.